Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer

This study has been completed.
Sponsor:
Collaborator:
University of Arizona
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00245024
First received: October 25, 2005
Last updated: May 1, 2013
Last verified: October 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2010
  Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)